Hyperfine Inc. (HYPR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.96
-0.02 (-2.04%)
At close: Jan 15, 2025, 3:59 PM
0.96
0.00%
After-hours Jan 15, 2025, 04:00 PM EST
Company Description
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products.
It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services.
The company was incorporated in 2014 and is based in Guilford, Connecticut.
Hyperfine Inc.
Country | United States |
IPO Date | Jan 28, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 131 |
CEO | Maria Sainz |
Contact Details
Address: 351 New Whitfield Street Guilford, Connecticut United States | |
Website | https://hyperfine.io |
Stock Details
Ticker Symbol | HYPR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001833769 |
CUSIP Number | 44916K106 |
ISIN Number | US44916K1060 |
Employer ID | 00-0000000 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Maria Sainz | Chief Executive Officer, President & Director |
Brett Hale | Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary |
Dr. Thomas Teisseyre Ph.D. | Chief Operating Officer |
Dave Castiglioni | Chief Commercial Officer |
Dr. Jonathan M. Rothberg Ph.D. | Founder & Vice Chairman |
Edmond Knopp M.D. | Chief Medical Officer |
R. Scott Huennekens CPA, M.B.A. | Executive Chairman |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 18, 2024 | 4 | Filing |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Aug 16, 2024 | 4 | Filing |
Aug 09, 2024 | 10-Q | Quarterly Report |
Aug 08, 2024 | 8-K | Current Report |
Jul 24, 2024 | 8-K | Current Report |
Jun 12, 2024 | 4 | Filing |
Jun 12, 2024 | 4 | Filing |
Jun 12, 2024 | 4 | Filing |